Bumrungrad International Hospital
| Thailand | Turkey | Austria | |
| Target therapy for lung cancer | - | from $5,000 / ฿170,000 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Target therapy for lung cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Target therapy for lung cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Target therapy for lung cancer journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Preparing for Target Therapy
Day 4 - Target Therapy
Day 5 - Post-Operation
Week 1 - Rehabilitation
Week 2-4 - Rehabilitation
Month 2-3 - Final Result
Please note that the recovery process can vary depending on individual health conditions and how the body responds to the treatment.
As the leading global medical tourism platform, Bookimed.com takes the responsibility to provide its clients — both patients and medical centers — with high-quality information related to Target therapy for lung cancer and Thailand. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product.
Bookimed.com forms listings of clinics and doctors related to Target therapy for lung cancer in Thailand with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Bookimed.com"s experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
Bookimed.com collects the opinions of patients who have received medical treatment in Thailand for Target therapy for lung cancer only after their experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers in Thailand for Target therapy for lung cancer just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Bookimed.com"s blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information related to Target therapy for lung cancer in Thailand, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com related to Target therapy for lung cancer in Thailand, please feel free to contact us at marketing@bookimed.com.
Targeted therapy for lung cancer is generally safer than chemotherapy because it specifically attacks cancer cells while sparing healthy tissue. Most patients manage side effects well under supervision at Joint Commission International (JCI) accredited facilities like Bumrungrad International Hospital in Bangkok, which serves 1,000,000 patients annually.
Bookimed Expert Insight: Data from top-tier Thai oncology departments shows that comprehensive genetic testing is the most critical safety step. Clinics like Bumrungrad International Hospital utilize advanced digital imaging and AI to monitor drug resistance, which typically occurs after 10-14 months. Knowing the next treatment sequence beforehand significantly improves the patient experience.
Patient Consensus: Many patients find the side effects like skin reactions manageable but emphasize that brain fog and fatigue are often underestimated. Most agree that having a clear plan for drug switches is essential for peace of mind.
To ensure high-quality target therapy for lung cancer in Thailand, prioritize oncologists with Thai Board of Medical Oncology certification and international fellowships. Look for specialists at JCI-accredited facilities like Bumrungrad International Hospital who demonstrate expertise in genomic profiling and NGS testing for specific mutations like EGFR, ALK, or ROS1.
Bookimed Expert Insight: Many patients overlook that top Thai oncologists at Bumrungrad International Hospital often hold dual certifications. With over 50% of their 1 million annual patients coming from abroad, these specialists are uniquely adapted to international protocols. When selecting a doctor, specifically ask for their PubMed publication count regarding targeted therapies to verify their clinical authority.
Patient Consensus: Patients emphasize the importance of choosing communicative specialists who prioritize precision medicine. They often recommend verifying NGS testing capabilities early to ensure the treatment plan aligns with the latest NCCN guidelines.
Comprehensive lung cancer targeted therapy packages in Thailand include advanced biomarker testing for mutations like EGFR or ALK and personalized drug protocols. These programs bundle oncology consultations, diagnostic imaging, and pharmacy services to precisely attack cancer cells while minimizing damage to healthy tissue.
Bookimed Expert Insight: Data from top-tier centers like Bumrungrad International Hospital shows a significant focus on international coordination. While basic packages cover initial drug cycles, patients should confirm if newer generation agents are stocked. Some advanced therapies cost 200,000 to 400,000 THB monthly and may require separate billing. Always verify if the package price includes these specific high-cost medications before starting.
Patient Consensus: Patients emphasize requesting an itemized list of included drugs to avoid unexpected costs. Many noted that genetic testing can add 2 to 4 weeks to the timeline.
Patients typically stay in Thailand for 14 to 21 days during the initial phase. This timeframe allows for essential genetic marker testing, specialist consultations at JCI-accredited facilities like Bumrungrad International Hospital, and monitoring after the first treatment cycle to manage any immediate side effects safely.
Bookimed Expert Insight: Data from Bumrungrad International Hospital shows that 50% of their 1 million annual patients are international. Because they use advanced digital imaging and EHRs, patients can often coordinate biopsy results remotely. This often reduces the first physical trip from 3 weeks down to 10 days.
Patient Consensus: Many patients recommend planning a minimum 2-week first trip for testing and setup. They emphasize confirming if your specific therapy is oral or IV before booking travel to avoid stay extensions.
Thailand is an ideal destination for lung cancer targeted therapy due to its JCI-accredited oncology centers and internationally trained specialists. Facilities like Bumrungrad International Hospital combine advanced molecular testing with significant cost advantages. Patients access cutting-edge drug protocols and personalized precision medicine within high-tech, patient-centric environments.
Bookimed Expert Insight: While Thailand offers world-class care, data suggests using it as a cost-effective treatment hub rather than a primary diagnostic center. You should secure your mutation testing at home first to ensure the Thai protocol matches your specific cancer profile. This cross-verification prevents delays once you arrive in Bangkok.
Patient Consensus: Patients value the significant savings on expensive medications but warn about the difficulty of transferring medical records back home. It is essential to secure all English-language treatment plans and imaging results before your departure to ensure seamless follow-up care.
Targeted therapy for lung cancer in Thailand is predominantly an outpatient procedure. Patients typically receive oral medications to take at home or undergo intravenous infusions in specialized oncology clinics. Hospitalization is rarely required unless initial doses need intensive monitoring for potential allergic reactions or complex combination treatments.
Bookimed Expert Insight: Data from major Bangkok centers shows a shift toward home-based care for EGFR-mutant lung cancer. While surgery may cost between $18,000 and $32,000, targeted therapy avoids high room charges. Many international patients successfully manage their entire treatment cycle from a nearby hotel rather than a hospital bed.
Patient Consensus: Patients value the convenience of `day procedures` where they receive infusions and return to their hotel immediately. It is frequently recommended to arrange a driver for the first visit in case of post-infusion fatigue.
Oncologists in Thailand determine eligibility for targeted lung cancer therapy through molecular biomarker testing and genetic tumour analysis. Specialists at JCI-accredited centres like Bumrungrad International Hospital identify specific mutations, such as EGFR or ALK. This confirms the cancer responds to precision drugs.
Bookimed Expert Insight: Thai oncology centres specialise in EGFR mutations, which appear in 50% of Asian non-smokers with lung cancer. Leading facilities like Bumrungrad International Hospital use telemedicine to review pathology reports before patients fly. This can save weeks of waiting for diagnostic results in Bangkok.
Patient Consensus: Tests in Thailand are thorough. Doctors identify the specific mutations that drive the cancer. Bringing previous pathology results speeds up the process. The staff focus on finding the most precise treatment plan for each case.
When lung cancer resists targeted therapy in Thailand, specialists pivot to next-line protocols. These follow Pan-Asian ESMO guidelines. This process involves repeat biomarker testing to identify new mutations. Doctors then switch to drugs like third-generation TKIs, platinum-doublet chemotherapy, or stereotactic radiation.
Bookimed Expert Insight: Thailand is a regional leader with 150+ clinics specialising in targeted therapy. Leading facilities like Bumrungrad International Hospital serve over 500,000 international patients annually. This volume means oncologists have seen virtually every resistance pattern. This includes secondary T790M mutations and small cell transformations.
Patient Consensus: Patients find that resistance is often detected on routine scans before symptoms appear. Keeping digital records of pathology helps Thai teams act quickly if drugs change. Continuity of care is essential. Confirm that second-line drugs are available before travelling.
Targeted therapy for lung cancer is a precision medicine. It blocks specific genetic mutations, such as EGFR or ALK, that drive tumour growth. Unlike chemotherapy, which kills all rapidly dividing cells, targeted drugs spare healthy tissue to minimise side effects.
Bookimed Expert Insight: While chemotherapy is standard, high-volume centres in Bangkok perform molecular testing for EGFR, ALK, and ROS1 mutations. Bumrungrad International Hospital serves over 500,000 international patients annually. This scale means their labs have the experience needed to identify rare biomarkers.
Patient Consensus: Patients in Thailand found that targeted therapy felt less aggressive than traditional chemo. They suggest requesting all molecular pathology reports in English to help with future care.
Targeted therapy in Thailand is only suitable for non-small cell lung cancer (NSCLC) with specific genetic mutations. It is not an option for small cell lung cancer (SCLC). Suitability requires biomarker testing to identify drivers like EGFR, ALK, or ROS1 before starting treatment.
Bookimed Expert Insight: Targeted drugs are available at 150+ Thai clinics. High-volume centres like Bumrungrad handle 500,000+ international patients yearly. Their scale provides immediate access to molecular testing and drug varieties that smaller clinics often lack.
Patient Consensus: Patients find that full molecular profiling in Thailand is essential for a clear plan. They value the kind, helpful staff and the ability to continue monitoring through telemedicine once they return home.
Thailand's leading oncology centres for targeted therapy include Bumrungrad International Hospital, Wattanosoth Cancer Hospital, and MedPark Hospital. These Bangkok-based facilities specialise in molecular diagnostics for EGFR and ALK mutations. They hold JCI accreditation and provide high-quality care for patients with lung cancer.
Bookimed Expert Insight: Bumrungrad International Hospital serves over 500,000 international patients annually. It holds Global Healthcare Accreditation (GHA). This certification ensures their processes are purpose-built for foreign patients. This makes logistics and medical record transfers much smoother for those travelling from Australia.
Patient Consensus: Fast molecular testing and accessing the right oncologist are more important than hospital amenities. Patients in Thailand suggest bringing all existing pathology and imaging reports to avoid treatment delays.
Targeted therapy in Thailand is given as daily oral tablets or via intravenous infusions at a specialist oncology centre. Delivery depends on genetic mutations found through molecular profiling. Most patients attend outpatient clinics for monitoring while staying in nearby serviced apartments.
Bookimed Expert Insight: Bumrungrad International Hospital serves over 1,000,000 patients annually with half coming from overseas. This massive international volume means their oncology teams are highly efficient. They coordinate with Australian GPs to keep long-term treatment plans consistent once the patient returns home.
Patient Consensus: Patients find the coordination teams very helpful and punctual during their stay in Thailand. Most recommend confirming whether therapy is oral or intravenous before travel to plan accommodation properly.